Rhythm Biosciences Limited (ASX:RHY)
Australia
· Delayed Price · Currency is AUD 0.0640
0.00 (0.00%)
May 15, 2025, 10:11 AM AEST
Rhythm Biosciences Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2017 - 2019 |
| Other Revenue | 1.69 | 1.69 | 3.1 | 2.43 | 1.11 | 0.1 | Upgrade
|
| Revenue | 3.17 | 1.69 | 3.1 | 2.43 | 1.11 | 0.1 | Upgrade
|
| Revenue Growth (YoY) | 53.33% | -45.41% | 27.54% | 118.98% | 1008.51% | -90.27% | Upgrade
|
| Cost of Revenue | -0.85 | 3.05 | - | - | - | - | Upgrade
|
| Gross Profit | 4.02 | -1.36 | 3.1 | 2.43 | 1.11 | 0.1 | Upgrade
|
| Selling, General & Admin | 3.6 | 3 | 7.7 | 5.99 | 3.03 | 2.08 | Upgrade
|
| Research & Development | 2.35 | 2.35 | 3.65 | 5.16 | 4.55 | 1.94 | Upgrade
|
| Operating Expenses | 6.14 | 5.55 | 11.54 | 11.25 | 7.73 | 4.16 | Upgrade
|
| Operating Income | -2.12 | -6.91 | -8.44 | -8.82 | -6.62 | -4.06 | Upgrade
|
| Interest Expense | -0.06 | -0 | -0.01 | - | -0 | -0.01 | Upgrade
|
| Interest & Investment Income | 0.1 | 0.05 | 0.23 | 0.02 | 0.01 | 0.05 | Upgrade
|
| Pretax Income | -2.18 | -6.86 | -8.22 | -8.79 | -6.61 | -4.02 | Upgrade
|
| Net Income | -2.18 | -6.86 | -8.22 | -8.79 | -6.61 | -4.02 | Upgrade
|
| Net Income to Common | -2.18 | -6.86 | -8.22 | -8.79 | -6.61 | -4.02 | Upgrade
|
| Shares Outstanding (Basic) | 246 | 228 | 217 | 210 | 185 | 101 | Upgrade
|
| Shares Outstanding (Diluted) | 246 | 228 | 217 | 210 | 185 | 101 | Upgrade
|
| Shares Change (YoY) | 12.11% | 5.26% | 3.31% | 13.35% | 83.84% | - | Upgrade
|
| EPS (Basic) | -0.01 | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 | Upgrade
|
| Free Cash Flow | -2.12 | -6.22 | -7.06 | -6.52 | -5.47 | -2.79 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 | Upgrade
|
| Gross Margin | 126.84% | -80.31% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -67.03% | -408.60% | -272.60% | -363.29% | -597.64% | -4061.45% | Upgrade
|
| Profit Margin | -68.73% | -405.69% | -265.44% | -362.26% | -596.49% | -4022.98% | Upgrade
|
| Free Cash Flow Margin | -66.92% | -367.98% | -227.94% | -268.74% | -493.52% | -2788.13% | Upgrade
|
| EBITDA | -2.02 | -6.8 | -8.34 | -8.72 | -6.52 | -3.97 | Upgrade
|
| EBITDA Margin | -63.88% | - | -269.35% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.1 | 0.11 | 0.1 | 0.09 | 0.11 | 0.1 | Upgrade
|
| EBIT | -2.12 | -6.91 | -8.44 | -8.82 | -6.62 | -4.06 | Upgrade
|
| EBIT Margin | -67.03% | - | -272.60% | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.